Thorium-229 is a valuable, but scarce, radionuclide for nuclear clock applications or targeted alpha therapy. While it is mostly produced by the decay of 233U, 229Th can also be produced by neutron irradiation of 226Ra. At SCK•CEN, capsules containing mainly 228Th (by-product of 226Ra irradiation) were characterized to quantify the present amounts of 229Th, 228Th, 227Ac, 226Ra with high resolution gamma spectroscopy, after a decay period of 40 years in which 228Th has decayed. High purity 229Th was quantified, and after recovery using radiochemical separation processes, it can be used to support ongoing research.status: publishe
International audienceStudies have been devoted to the production of alpha emitters for medical appl...
The limited number of radionuclides emitting alpha-particles and their limited availability is discu...
A new approach to observe the radiative decay of the $^{229}$Th nuclear isomer, and to determine its...
In the United States, cancer is the second leading cause of death and a major public health problem ...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
The high therapeutic effect of targeted radioisotope/radionuclide therapy (TRT) using α-emitters, es...
In the whole landscape of atomic nuclei, 229Th is currently the only known nucleus which could allow...
The radionuclide thorium-229 features an isomer with an exceptionally low excitation energy that ena...
A procedure is described for the accelerator production of 232 Pa and its isolation in radiochemical...
225Ac [Actinium-225] is a promising radionuclide for targeted alpha therapy of cancer. 229Pa can lea...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...
A new approach to observe the radiative decay of the Th-229 nuclear isomer, and to determine its ene...
The general prospects of several radioisotopes are reviewed; the special properties of U/sup 232/ an...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
International audienceStudies have been devoted to the production of alpha emitters for medical appl...
The limited number of radionuclides emitting alpha-particles and their limited availability is discu...
A new approach to observe the radiative decay of the $^{229}$Th nuclear isomer, and to determine its...
In the United States, cancer is the second leading cause of death and a major public health problem ...
Actinium-225 has important medical applications as an agent for targeted alpha therapy, but existing...
International audienceThe irradiation of a thorium target by light charged particles (protons and de...
The high therapeutic effect of targeted radioisotope/radionuclide therapy (TRT) using α-emitters, es...
In the whole landscape of atomic nuclei, 229Th is currently the only known nucleus which could allow...
The radionuclide thorium-229 features an isomer with an exceptionally low excitation energy that ena...
A procedure is described for the accelerator production of 232 Pa and its isolation in radiochemical...
225Ac [Actinium-225] is a promising radionuclide for targeted alpha therapy of cancer. 229Pa can lea...
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons...
A new approach to observe the radiative decay of the Th-229 nuclear isomer, and to determine its ene...
The general prospects of several radioisotopes are reviewed; the special properties of U/sup 232/ an...
This thesis deals with the idea of using accelerator driven systems for thorium transmutation into t...
International audienceStudies have been devoted to the production of alpha emitters for medical appl...
The limited number of radionuclides emitting alpha-particles and their limited availability is discu...
A new approach to observe the radiative decay of the $^{229}$Th nuclear isomer, and to determine its...